WallStreetZenWallStreetZen

NASDAQ: CTKB
Cytek Biosciences Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cytek Biosciences earnings were -$10.2M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest CTKB earnings report on Sep 30, 2024 announced Q3 2024 earnings of $941.0k, down 109% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CTKB reported annual earnings of -$12.1M, with -571.6% growth.

CTKB past earnings growth

How has CTKB's earnings growth performed historically?

Company
N/A
Industry
32.37%
Market
53.89%
CTKB's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CTKB's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance

CTKB earnings history

Current Revenue
$201.2M
Current Earnings
-$10.2M
Current Profit Margin
-5%

CTKB Return on Equity

Current Company
-2.6%
Current Industry
11.4%
Current Market
35%
CTKB's Return on Equity (-2.6%)... subscribe to Premium to read more.
High Return on Equity Performance

CTKB Return on Assets

Current Company
-2.1%
Current Industry
6.6%
CTKB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CTKB announces earnings.

CTKB Return on Capital Employed

Current Company
-2.53%
Current Industry
8.8%
CTKB's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CTKB vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CTKB-$649.00k-$10.16M+3,609.96%$940.91
SIBN-$29.13M-$37.40MN/A-$0.92
IRMD$24.44M$18.63M+14.87%$1.48
OFIX-$38.97M-$119.03MN/A-$3.13
TMCI-$47.13M-$61.52MN/A-$0.99
View Top Medical Device Stocks

Cytek Biosciences Earnings Reports & History FAQ

What were Cytek Biosciences's earnings last quarter?

Cytek Biosciences (NASDAQ: CTKB) reported Q3 2024 earnings per share (EPS) of $941.00, up 114.58% year over year. Total CTKB earnings for the quarter were $941.00 thousand. In the same quarter last year, Cytek Biosciences's earnings per share (EPS) was -$6,456.00.

If you're new to stock investing, here's how to buy Cytek Biosciences stock.

Is Cytek Biosciences profitable or losing money?

As of the last Cytek Biosciences earnings report, Cytek Biosciences is currently losing money. Cytek Biosciences's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$10.16 million, a 28.06% decrease year over year.

What was CTKB's earnings growth in the past year?

As of Cytek Biosciences's earnings date in Q1 2025, Cytek Biosciences's earnings has grown year over year. CTKB earnings in the past year totalled -$10.16 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.